The overall goal of this study is to define the biochemical alterations that occur in oligosaccharides of cell surface glycoproteins during differentiation and during the functional expression of T lymphocytes and natural killer cells. The expression of N-linked oligosaccharides will be examined from whole cells as well those from specific glycoproteins, Thy1 and Ly5/T200, which exhibit differentiation related alterations. The highest priority of the study is the characterization of oligosaccharides containing polylactosamine structures because they have been recognized to be associated with differentiation and maturation in a number of biological systems, most notably the hematopoietic system. The cell types to be used in the current study will encompass T lymphoid and natural killer (NK) cells at various stages of differentiation and maturation. Cloned T and NK cells with different cytolytic or helper functions will also be studied. The biochemical characterization of cell surface glycoproteins will be accomplished using serial lectin chromatography, polylactosamine specific Datura stramonium and tomato lectins, and binding to anti-Ii affinity columns. Cell surface polylactosamine expression will be related to oligosaccharide alterations observed during ontogeny and maturation in the hematopoietic system. The role of oligosaccharides will be studied in anti-Thy1 induced T cell proliferation and NK-tumor cell adhesion and subsequent lysis. The identification of specific oligosaccharide alterations in discrete subsets of cells that have specific biological roles will be an important step in our understanding of differentiation, development and transformation.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM035774-01A1
Application #
3288982
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1986-07-01
Project End
1989-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Michigan State University
Department
Type
Schools of Medicine
DUNS #
193247145
City
East Lansing
State
MI
Country
United States
Zip Code
48824
Zhai, Y F; Wirth, J J; Welsch, C W et al. (1996) Protein tyrosine phosphatases: cellular regulators of human breast cancer? Cancer Treat Res 83:107-25
Zhai, Y; Wirth, J; Kang, S et al. (1995) LAR-PTPase cDNA transfection suppression of tumor growth of neu oncogene-transformed human breast carcinoma cells. Mol Carcinog 14:103-10
Melkerson-Watson, L J; Waldmann, M E; Gunter, A D et al. (1994) Elevation of lymphocyte CD45 protein tyrosine phosphatase activity during mitosis. J Immunol 153:2004-13
Zhai, Y F; Beittenmiller, H; Wang, B et al. (1993) Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res 53:2272-8
Zhai, Y F; Esselman, W J; Oakley, C S et al. (1992) Growth of MCF-7 human breast carcinoma in severe combined immunodeficient mice: growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells. Cancer Immunol Immunother 35:237-45
Bretz, J D; Chen, S C; Redenius, D et al. (1992) Lineage switch macrophages can present antigen. Dev Immunol 2:249-61
Chang, H L; Lefrancois, L; Zaroukian, M H et al. (1991) Developmental expression of CD45 alternate exons in murine T cells. Evidence of additional alternate exon use. J Immunol 147:1687-93
Chang, H L; Zaroukian, M H; Esselman, W J (1989) T200 alternate exon use in murine lymphoid cells determined by reverse transcription-polymerase chain reaction. J Immunol 143:315-21
Chang, H L; Zaroukian, M H; Morrison, M H et al. (1989) Adherent lymphokine-activated natural killer cells in normal and severe combined immunodeficiency mice: large granular lymphocytes with natural killer cell phenotype and high cytolytic activity. Nat Immun Cell Growth Regul 8:89-99
Gilbert, C W; Zaroukian, M H; Esselman, W J (1988) Poly-N-acetyllactosamine structures on murine cell surface T200 glycoprotein participate in natural killer cell binding to YAC-1 targets. J Immunol 140:2821-8

Showing the most recent 10 out of 11 publications